insitro

insitro is an artificial intelligence company in South San Francisco, United States, founded in 2018. It has raised $643.0M across 3 rounds, most recently a $400.0M Series C in March 2021.

Making Medicines Differently

Employees
201–500
Founded
2018
Business Model
B2B
Total Funding
$643.0M
Last Round
$400.0M Series CMar 2021
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 9 investors for this company. The full record is or through the API.

About

insitro is a machine learning-driven drug discovery company that integrates in vitro cellular data from automated labs with human clinical data to identify novel disease targets and therapeutics. The company builds a wholly-owned and partnered pipeline across metabolism, oncology, and neuroscience, with programs including POSH (CRISPR screening + Vision Transformers) and TherML therapeutic design.

Summary

It lists 201–500 employees. It has raised $643.0M in total across 3 rounds, most recently a $400.0M Series C round in Mar 2021. Investors include Andreessen Horowitz, Canada Pension Plan Investment Board and T. Rowe Price.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series CSeries CMar 2021
$400.0M

Sign up to see all 3 events

Funding: Series A through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Devoted Health

Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Waltham, United States1001–5000Artificial Intelligence, Healthcare
Series G+Total funding$3.5BOct 2026
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Verily Life Sciences

Verily builds AI-native precision health platforms that help healthcare organizations harmonize d...

Dallas, United States1001–5000Artificial Intelligence, Healthcare
Corporate RoundTotal funding$3.0BMar 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

insitro on Indexed.vc
<a href="https://indexed.vc/companies/insitro"><img src="https://indexed.vc/api/badge/company/insitro" alt="insitro on Indexed.vc" width="260" height="76" /></a>